<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> AP880308-0306 </DOCNO><FILEID>AP-NR-03-08-88 1533EST</FILEID><FIRST>r f AM-Corning-ClinicalLabs     03-08 0187</FIRST><SECOND>AM-Corning-Clinical Labs,0199</SECOND><HEAD>Corning Glass To Acquire Clinical Labs</HEAD><DATELINE>CORNING, N.Y. (AP) </DATELINE><TEXT>   Corning Glass Works said Tuesday that ithas agreed to acquire International Clinical Laboratories in a cashdeal valued at around $260 million.   Chairman James Houghton said he hoped the merger would broadenCorning's laboratory services. The company said it planned tocombine Nashville-based International Clinical with its laboratorysubsidiary, MePath Inc.   Corning said it offered $26 a share for 3 million unissuedshares of International Clinical stock and has an option to buy allof the shares owned by certain directors and officers of thecompany.   The deal, which is set to expire by March 28, is subject tofederal approval and to Corning acquiring a majority ofInternational Clinical's shares.   International Clinical operates 13 major laboratories, mainly inthe South and West, and had sales of $205 million last fiscal yearand net income of $4.8 million.   Besides laboratory services, Corning makes consumer housewares,optical fibers and other telecommunications equipment, andspecialty glass and ceramics.   Its MetPath subisidiary, which is based in Teterboro, N.J., hasabout a dozen testing labs nationwide.</TEXT></DOC>